Works matching IS 03407004 AND DT 2014 AND VI 63 AND IP 2
Results: 10
HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 2, p. 101, doi. 10.1007/s00262-013-1489-4
- By:
- Publication type:
- Article
Advances in cellular therapy: 7th international symposium on the clinical use of cellular products, March 14 and 15, 2013, Erlangen, Germany.
- Published in:
- 2014
- By:
- Publication type:
- Report
Critical role of spatial interaction between CD8 and Foxp3 cells in human gastric cancer: the distance matters.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 2, p. 111, doi. 10.1007/s00262-013-1491-x
- By:
- Publication type:
- Article
Identification and characterization of agonist epitopes of the MUC1-C oncoprotein.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 2, p. 161, doi. 10.1007/s00262-013-1494-7
- By:
- Publication type:
- Article
The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 2, p. 175, doi. 10.1007/s00262-013-1502-y
- By:
- Publication type:
- Article
Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 2, p. 133, doi. 10.1007/s00262-013-1492-9
- By:
- Publication type:
- Article
Neuropilin 1: function and therapeutic potential in cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 2, p. 81, doi. 10.1007/s00262-013-1500-0
- By:
- Publication type:
- Article
An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 2, p. 121, doi. 10.1007/s00262-013-1497-4
- By:
- Publication type:
- Article
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 2, p. 147, doi. 10.1007/s00262-013-1499-2
- By:
- Publication type:
- Article
Acknowledgement.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 2, p. 195, doi. 10.1007/s00262-014-1517-z
- Publication type:
- Article